Professional Documents
Culture Documents
... Introducing
Teneligliptin 20 mg
2 %
1.33% 0.94% 0.81% 0.56%
10 9.59 9.22 9.58
8.3 8.26 8.38 8.77
7.92
8 7.36
HbA1c Reduction 6.3
6
2 Baseline
Post-treatment
0
Vildagliptin Sitagliptin Linagliptin Saxagliptin
Reference
Teneligliptin 20 mg
1. 2. 3.
Adds Glitter to Every Moment of Life!
Diabetol Metab Syndr (2015) 7:91 Drugs R D (2015) 15:245–251 BMC Endocrine Disorders 2014, 14:17
Glytrin - Newest Generation of DPP-4 Inhibitor
Reference
Teneligliptin 20 mg
1. 2. 3. 4. 5.
Adds Glitter to Every Moment of Life!
Drugs Today (Barc). Clin Drug Investig Diabetes Metab Syndrome J Clin Med Res. Diabetes Obes Metab. *Sulphonylurea
2013 Oct;49(10):615-29. (2015) 35:765–772 2013, 6, 187-195 2014 Aug; 6(4): 287–294. 2014 May;16(5):418-25.
Glytrin: Brings Back the Glitter
With Prescribe in
1 Superior efficacy - highest Diabetes Mellitus
HbA1c reduction
2 Significant FPG and PPG reduction Newly diagnosed Diabetes
Mellitus Patients
3 Safe in patients with renal &
hepatic diseases Add On therapy with
4 One dose, once daily dosing
Metformin, SU & Insulin
Reference
Teneligliptin 20 mg
1. 2. 3. 4.
Adds Glitter to Every Moment of Life!
Drugs R D Clin Drug Investig Drugs Today (Barc). Product Prescribing
(2015) 15:245–251 (2015) 35:765–772 2013 Oct;49(10):615-29. Information